...
首页> 外文期刊>Acta orthopaedica. >Do non-steroidal anti-inflammatory drugs cause endoprosthetic loosening? A 10-year follow-up of a randomized trial on ibuprofen for prevention of heterotopic ossification after hip arthroplasty.
【24h】

Do non-steroidal anti-inflammatory drugs cause endoprosthetic loosening? A 10-year follow-up of a randomized trial on ibuprofen for prevention of heterotopic ossification after hip arthroplasty.

机译:非甾体类抗炎药会引起假体内松动吗?布洛芬预防髋关节置换术后异位骨化的随机试验的十年随访。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) are known to be potent inhibitors of new bone formation. We investigated whether NSAIDs given at surgery influence the long-term results after total hip arthroplasty (THA). PATIENTS AND METHODS: We performed a 10-year follow-up on 142 of 144 patients who had taken part in a randomized trial on the preventive effects of the NSAID ibuprofen on heterotopic ossification after THA. 96 patients were treated with ibuprofen: 48 for 1 week postoperatively, 48 for 2 weeks postoperatively, and 48 patients were not treated. RESULTS: 13 patients had been revised. All revisions except 1 belonged to groups treated with ibuprofen. The 10-year risk for revision was significantly higher in the ibuprofen-treated patients (p = 0.05). Eleven of the revisions occurred due to fractures of the femur (2) or aseptic loosening (9), reasons that may be attributed to negative effects of ibuprofen. For these patients, the 10-year risk for revision was not statistically significantly different between treated and untreated patients (p = 0.08). In addition to the revised patients, 94 other patients were alive at the 10-year follow-up and 84 underwent radiographic examination. 9 loose prostheses were found radiographically, but these were equally distributed between ibuprofen-treated and untreated hips. INTERPRETATION: The high proportion of revisions in the ibuprofen groups, in combination with clinical and experimental evidence of inhibitory effects on new bone formation of NSAIDs, warrants further investigation of the effects of these drugs on prosthetic fixation.
机译:背景:非甾体类抗炎药(NSAIDs)是新骨形成的有效抑制剂。我们调查了手术中给予的NSAID是否会影响全髋关节置换术(THA)后的长期结果。患者和方法:我们对参与随机试验的144名患者中的142名患者中的142名患者进行了为期10年的随访,研究了NSAID布洛芬对THA后异位骨化的预防作用。 96例患者接受布洛芬治疗:术后1周48例,术后2周48例,未治疗48例。结果:13例患者被修订。除1以外的所有修订均属于布洛芬治疗组。布洛芬治疗的患者10年翻修风险显着更高(p = 0.05)。其中11个翻修是由于股骨骨折(2)或无菌性松动(9)引起的,其原因可能是由于布洛芬的不良影响。对于这些患者,接受治疗和未经治疗的患者的10年翻修风险在统计学上无显着差异(p = 0.08)。除经修订的患者外,在10年的随访中还有94例患者还活着,其中84例接受了影像学检查。在影像学上发现9个松散的假体,但在布洛芬治疗和未治疗的髋关节之间均等分布。解释:布洛芬组中大量的修订,结合对非甾体抗炎药新骨形成具有抑制作用的临床和实验证据,有必要进一步研究这些药物对假体固定的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号